Considerations in upstream bioprocess monitoring and statistical data analysis in the context of process analytical technology and quality by design

Author： Striedner Gerald   Bayer Karl  

Publisher： Future Science

ISSN： 2048-9145

Source： Pharmaceutical Bioprocessing, Vol.1, Iss.2, 2013-06, pp. : 159-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Considerations for Design and Data Analysis of Noninferiority/Superiority Cardiovascular Trials

By Quan Hui   Li Mingyu   Zhao Peng-Liang   Cho Meehyung   Zhang Ji   Wu Yujun  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 239-260

Taylor & Francis Ltd

Access to resources Recommend Favorite

Statistical Optimization of Pharmacogenomics Association Studies: Key Considerations from Study Design to Analysis

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 1, 2011-03 ,pp. : 41-66

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention Trials: Design and Analysis Considerations

By Drye Lea T.   Meinert Curtis L.  

Pharmaceutical Medicine, Vol. 25, Iss. 6, 2011-12 ,pp. : 367-378

Adis International

Access to resources Recommend Favorite

Process Analytical Technology for Crystallization of Active Pharmaceutical Ingredients

By  

Current Pharmaceutical Design, Vol. 24, Iss. 21, 2018-06 ,pp. : 2456-2472

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of: “Statistical Analysis of Epidemiologic Data”

By Hudson Suzanne  

Journal of Biopharmaceutical Statistics, Vol. 15, Iss. 5, 2005-01 ,pp. : 885-887

Taylor & Francis Ltd

Access to resources Recommend Favorite